Nitric oxide (NO) donor. A convenient reagent for preparing aqueous solutions of NO.
Product Details
| Alternative Name: | SPER/NO, (Z)-1-{N-[3-Aminopropyl]-N-[4-(3-aminopropylammonio)butyl]-amino}-diazen-1-ium-1,2-diolate |
| |
| Formula: | C10H26N6O2 |
| |
| MW: | 262.4 |
| |
| CAS: | 136587-13-8 |
| |
| Purity: | ≥97% (NMR) |
| |
| Appearance: | White to off-white crystalline solid. |
| |
| Solubility: | Soluble in water, methanol or 100% ethanol. |
| |
| Shipping: | Blue Ice |
| |
| Long Term Storage: | -80°C |
| |
| Use/Stability: | Relatively stable in alkaline solution. |
| |
| Handling: | Protect from light and oxygen. Keep under inert gas. Hygroscopic. |
| |
| Technical Info/Product Notes: | Product dissociates to the free amine and nitric oxide in a pH dependent manner following first order kinetics. Alkaline solutions of NONOates (in 0.01M NaOH) are stable and can be stored at 0°C for 24 hours. To initiate the release of nitric oxide add alkaline solution of Spermine NONOate to excess buffer of pH 7.0 - 7.4. Relatively high concentrated solutions can be prepared for further dilution. Half life in 0.1M phosphate buffer (pH 7.4) at 37 C is t½ (min.) 39. Decomposition is nearly instantaneous at pH 5. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
P2X1 Receptors Amplify FcγRIIa-Induced Ca2+ Increases and Functional Responses in Human Platelets: Z. Ilkan, et al.; Thromb. Haemost.
118, 369 (2018),
Abstract;
Full Text
Subtle reproductive impairment through nitric oxide-mediated mechanisms in sea urchins from an area affected by harmful algal blooms: O. Migliaccio, et al.; Sci. Rep.
6, 26086 (2016),
Application(s): Cell culture,
Abstract;
Full Text
Excessive nitric oxide attenuates leptin-mediated signal transducer and activator of transcription 3 activation: E.H. Jang, et al.; Life Sci.
80, 609 (2007),
Abstract;
Inflammatory cytokines induce MAdCAM-1 in murine hepatic endothelial cells and mediate alpha-4 beta-7 integrin dependent lymphocyte endothelial adhesion in vitro: T. Ando, et al.; BMC Physiol.
7, 10 (2007),
Abstract;
Full Text
Effects of antioxidants and NO on TNF-alpha-induced adhesion molecule expression in human pulmonary microvascular endothelial cells: M.Z. Jiang, et al.; Respir. Med.
99, 580 (2005),
Abstract;
Effects of antioxidant and nitric oxide on chemokine production in TNF-alpha-stimulated human dermal microvascular endothelial cells: M.Z. Jiang, et al.; Free Radic. Res.
38, 473 (2004),
Abstract;
Extracellular nitric oxide release mediates soluble guanylate cyclase-independent vasodilator action of spermine NONOate: comparison with other nitric oxide donors in isolated rat femoral arteries: M.R. Miller, et al.; J. Cardiovasc. Pharmacol.
43, 440 (2004),
Abstract;
In vitro cytotoxicity of glyco-S-nitrosothiols. a novel class of nitric oxide donors: H. Babich & H.L. Zuckerbraun; Toxicol. In Vitro
15, 181 (2001),
Abstract;
In vitro cytotoxicity of the nitric oxide donor, S-nitroso-N-acetyl-penicillamine, towards cells from human oral tissue: H. Babich, et al.; Pharmacol. Toxicol.
84, 218 (1999),
Abstract;
New nitric oxide-releasing zwitterions derived from polyamines : J.A. Hrabie, et al.; J. Org. Chem. 58, 1472 (1993),
Nitric oxide/nucleophile complexes inhibit the in vitro proliferation of A375 melanoma cells via nitric oxide release: C.M. Maragos, et al.; Cancer Res.
53, 564 (1993),
Abstract;
Complexes of .NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects: C.M. Maragos, et al.; J. Med. Chem.
34, 3242 (1991),
Abstract;
